Raymond James Financial Cuts Itafos (CVE:IFOS) Price Target to C$3.75

Itafos (CVE:IFOSFree Report) had its price target reduced by Raymond James Financial from C$4.50 to C$3.75 in a research report released on Monday,BayStreet.CA reports. They currently have an outperform rating on the stock.

Itafos Stock Up 0.4%

Itafos stock opened at C$2.45 on Monday. The company has a market capitalization of C$477.21 million, a PE ratio of 9.42 and a beta of 0.02. Itafos has a 12-month low of C$2.15 and a 12-month high of C$4.67. The firm’s fifty day moving average is C$2.36 and its 200 day moving average is C$2.91. The company has a quick ratio of 0.72, a current ratio of 2.12 and a debt-to-equity ratio of 19.32.

About Itafos

(Get Free Report)

Itafos Inc operates as a phosphate and specialty fertilizer company. It operates through Conda, Arrais, and Development and Exploration segments. The company produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, hydrofluorosilicic acid, direct application phosphate rock, single superphosphate (SSP), SSP with micronutrients, and sulfuric acid. It also owns interests in the Farim, a phosphate mine project situated in Farim, Guinea-Bissau; Araxá, a rare earth element and niobium mine and extraction plant project that is situated in Minas Gerais, Brazil; Arraias, an integrated phosphate fertilizer project located in Tocantins, Brazil; and Santana, an integrated phosphate mine and fertilizer plant project located in Pará, Brazil.

Featured Articles

Receive News & Ratings for Itafos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itafos and related companies with MarketBeat.com's FREE daily email newsletter.